Contact this trialFirst, we need to learn more about you.
ATM Kinase Inhibitor
AZD1390 + SBRT for Metastatic Cancer
Recruiting1 awardPhase 1
Middletown, New Jersey
This trial is testing a new drug called AZD1390 combined with a precise form of radiation therapy to treat people with cancer that has spread to other parts of the body. The goal is to see if this combination is safe and effective. AZD1390 helps make cancer cells more vulnerable to radiation, potentially improving treatment outcomes.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service